IBT
OMER icon

International Biotechnology Trust’s Omeros OMER Stock Holding History

International Biotechnology Trust’s Portfolio OMER Stock Details OMER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-34,000
Closed -$660K – 67
2017
Q4 		$660K Sell
34,000
-27,000
-44% -$506K 0.23% 60
2017
Q3 		$1.32M Buy
61,000
+30,761
+102% +$652K 0.51% 40
2017
Q2 		$602K Buy
+30,239
New +$528K 0.23% 58

Other funds holding OMER

Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

International Biotechnology Trust's OMER Position: Q1 2018 in Review

International Biotechnology Trust sold out of Omeros (OMER) in Q1 2018, closing a stake of 34,000 shares — an estimated $660K sold.

International Biotechnology Trust first reported a position in OMER in Q2 2017 and held it in 3 quarters. The position peaked at $1.32M in Q3 2017. 112 funds tracked by Wall St. Rank hold OMER as of Q1 2018.

  • International Biotechnology Trust reported no remaining Omeros position as of Q1 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 34,000 Omeros shares in Q1 2018, an estimated $660K.
  • International Biotechnology Trust first reported a position in Omeros in Q2 2017 and held it in 3 quarters.
  • International Biotechnology Trust's Omeros position peaked at $1.32M in Q3 2017.
  • 112 funds tracked by Wall St. Rank held Omeros as of Q1 2018.

Based on International Biotechnology Trust's 13F filing for Q1 2018, filed 15 May 2018.